| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/31/2013 | WO2013015152A1 TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION |
| 01/31/2013 | WO2013014921A1 Agent for increasing serotonin in brain |
| 01/31/2013 | WO2013014629A1 Pharmaceutical compositions comprising pyrrole diones and their use to inhibit angiogenesis |
| 01/31/2013 | WO2013014274A1 5ht1a antagonist useful for in vivo imaging |
| 01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | WO2013014185A1 Bicyclic pyrimidone compounds |
| 01/31/2013 | WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
| 01/31/2013 | WO2013013817A1 Substituted heterocyclic aza derivatives |
| 01/31/2013 | WO2013013816A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | WO2013013815A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | WO2013013613A1 Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases |
| 01/31/2013 | WO2013013503A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors |
| 01/31/2013 | WO2013013498A1 Chinese medicine beverage for nourishing the heart to calm the mind |
| 01/31/2013 | WO2013013338A1 Use of substances targeting gc-c signaling pathway in diagnosis and treatment for midbrain dopamine neurons diseases |
| 01/31/2013 | WO2012170899A3 Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases |
| 01/31/2013 | WO2012167281A3 Clinical application utilizing genetic data for effective medication management |
| 01/31/2013 | WO2012159052A3 Targeted delivery of proteins across the blood brain barrier |
| 01/31/2013 | WO2012149295A3 Methods of administering anatabine to treat autism spectrum disorders and seizure disorders |
| 01/31/2013 | WO2011159871A8 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 01/31/2013 | WO2010063862A3 5,6-DIHYDRODIBENZO[b,f][1,4,5]THIADIAZEPINE DERIVATIVES AND THE USE THEREOF IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130030056 Methods of delivering pharmaceutical agents |
| 01/31/2013 | US20130030035 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 01/31/2013 | US20130030025 Use of potassium channel blockers to treat cerebral palsy |
| 01/31/2013 | US20130030024 Method of Administering Pirfenidone Therapy |
| 01/31/2013 | US20130030022 Compounds Which Selectively Modulate The CB2 Receptor |
| 01/31/2013 | US20130030020 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 01/31/2013 | US20130030018 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030011 Compounds for the reduction of beta-amyloid production |
| 01/31/2013 | US20130030000 Pharmaceutical compositions for the treatment of pain and other indications |
| 01/31/2013 | US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/31/2013 | US20130029998 Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases |
| 01/31/2013 | US20130029996 Special composition for the use thereof as a drug |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists |
| 01/31/2013 | US20130029989 Topical treatments for pain |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029983 Aminothienopyridazine inhibitors of tau assembly |
| 01/31/2013 | US20130029975 Cgrp antagonists |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029970 CB Receptor Agonists |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 01/31/2013 | US20130029965 Pharmaceutical solid dispersions |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029941 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 01/31/2013 | US20130029939 Novel glucokinase activators and methods of using same |
| 01/31/2013 | US20130029924 Glycosylated valproic acid analogs and uses thereof |
| 01/31/2013 | US20130029916 Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate |
| 01/31/2013 | US20130029902 Cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | US20130028994 Pomegranate extract having a high ellagic acid content, and use of the pomegranate extract |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028985 Composition and method for treating migraines |
| 01/31/2013 | US20130028972 Tamper-resistant tablet providing immediate drug release |
| 01/31/2013 | US20130028970 Tamper-resistant tablet providing immediate drug release |
| 01/31/2013 | US20130028956 Method for preventing or treating memory impairment and pharmaceutical compositions useful therefore |
| 01/31/2013 | US20130028955 Sustained release oral matrix and methods of making thereof |
| 01/31/2013 | US20130028947 Pharmaceutical composition for topical application |
| 01/31/2013 | US20130028943 Melatonin tablet and methods of preparation and use |
| 01/31/2013 | US20130028938 Solid pharmaceutical dosage form |
| 01/31/2013 | US20130028937 Co-crystals of venlafaxine and celecoxib |
| 01/31/2013 | US20130028921 Composition comprising coumestrol or a bean extract containing coumestrol |
| 01/31/2013 | US20130028916 Antagonist anti-il-7 receptor antibodies and methods |
| 01/31/2013 | US20130028914 Antibodies that Bind Tau Oligomers |
| 01/31/2013 | US20130028900 Methods and compositions for the generation and use of conformation-specific antibodies |
| 01/31/2013 | US20130028892 Method of treating osteoarthritis with an antibody to ngf |
| 01/31/2013 | US20130028887 Phenylacetic acid compound |
| 01/31/2013 | US20130028881 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 01/31/2013 | US20130028874 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 01/31/2013 | US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| 01/31/2013 | US20130028867 Long-acting interferon beta formulation using immunoglobulin fragment |
| 01/31/2013 | US20130028866 Treatment of multiple sclerosis with combination of laquinimod and interferon-beta |
| 01/31/2013 | US20130028864 Anti-inflammatory compositions for treating brain inflammation |
| 01/31/2013 | US20130028861 Cytokines for the treatment of addictions |
| 01/31/2013 | US20130028860 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 01/31/2013 | US20130028849 Agent For Stimulating The Expression of Loxl |
| 01/31/2013 | US20130028842 Method of treating binge eating disorder |
| 01/31/2013 | CA2843374A1 Method for the treatment of addiction to tobacco |
| 01/31/2013 | CA2843251A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | CA2843102A1 Bicyclic pyrimidone compounds |
| 01/31/2013 | CA2843014A1 Use of il-12 to generate endogenous erythropoietin |
| 01/31/2013 | CA2842983A1 Substituted heterocyclic aza derivatives |
| 01/31/2013 | CA2842976A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | CA2842969A1 Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases |
| 01/31/2013 | CA2842965A1 2,3-dihydroimidazo[1,2-c] pyrimidin-5(1h)-one compounds use as lp-pla2 inhibitors |
| 01/31/2013 | CA2842916A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | CA2842866A1 Alpha-2 adrenergic modulators for treating visual disorders mediated by central visual projections from the eye |
| 01/31/2013 | CA2842580A1 Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mrna to inhibit translation reaction |
| 01/31/2013 | CA2842524A1 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/31/2013 | CA2842106A1 Cysteine prodrugs |
| 01/31/2013 | CA2841905A1 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | CA2837732A1 Methylphenidate-prodrugs, processes of making and using the same |
| 01/30/2013 | EP2551281A1 Splice variants of GDNF and uses thereof |